Literature DB >> 16391913

Bacteremia caused by the novel species Mycobacterium canariasense.

M I Campos-Herrero1, D García, A Figuerola, P Suárez, C Campo, M J García.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391913     DOI: 10.1007/s10096-005-0079-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review.

Authors:  V Roy; D Weisdorf
Journal:  Bone Marrow Transplant       Date:  1997-03       Impact factor: 5.483

2.  Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient.

Authors:  P H McWhinney; M Yates; H G Prentice; M Thrussell; S H Gillespie; C C Kibbler
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

3.  Mycobacterium canariasense sp. nov.

Authors:  M Soledad Jiménez; M Isolina Campos-Herrero; Diana García; Marina Luquin; Laura Herrera; María J García
Journal:  Int J Syst Evol Microbiol       Date:  2004-09       Impact factor: 2.747

4.  Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters.

Authors:  J F Hoy; K V Rolston; R L Hopfer; G P Bodey
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

5.  Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin.

Authors:  L Jadeja; R Bolivar; R J Wallace; V A Silcox; G P Bodey
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

Review 6.  Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review.

Authors:  I I Raad; S Vartivarian; A Khan; G P Bodey
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

7.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

Authors:  R J Wallace; J M Swenson; V A Silcox; M G Bullen
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

Review 8.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

9.  Non-tuberculous mycobacterial infection in children with cancer.

Authors:  J C Graham; D A Tweddle; D R Jenkins; C Pollitt; S J Pedler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 5.103

  9 in total
  5 in total

1.  Case report and literature review: double jeopardy - Exophiala dermatitidis and Mycobacterium canariasense central line-associated bloodstream infection in a patient.

Authors:  Afrinash Ahamad; Bushra Tehreem; Maaz Farooqi; Bennadette Maramara
Journal:  Access Microbiol       Date:  2022-04-19

2.  First report of Mycobacterium canariasense catheter-related bacteremia in the Americas.

Authors:  Alberto Paniz-Mondolfi; Lynn Ladutko; Barbara A Brown-Elliott; Ravikiran Vasireddy; Sruthi Vasireddy; Richard J Wallace; Wesley Jakubiec; Stephen Brecher; Sheldon Campbell
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

3.  A Novel Mycobacterium cosmeticum-Like Bacterium Isolated from the Ear Swab of a Patient with Otitis Externa.

Authors:  Jeanette W P Teo; Janet W S Cheng; Roland Jureen; Raymond T P Lin
Journal:  Case Rep Infect Dis       Date:  2015-03-17

4.  Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran.

Authors:  Fatemeh Sakhaee; Farzam Vaziri; Golnaz Bahramali; Kambiz Taremian; Seyed Davar Siadat; Abolfazl Fateh
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

5.  Mycobacterial infection of breast prosthesis--a conservative treatment: a case report.

Authors:  David Atallah; Nadine El Kassis; George Araj; Marwan Nasr; Roy Nasnas; Nicolas Veziris; Dolla Sarkis
Journal:  BMC Infect Dis       Date:  2014-05-05       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.